Clinical efficacy and safety of Lyprinol®, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: A multicenter 2-month clinical trial

European Annals of Allergy and Clinical Immunology

Volumn 35, Issue 6, 2003, Pages 212-216

  Cho, Se Haeng ^a   Jung, Young Bok ^b   Seong, Sang Cheol ^c   Park, Hyung Bin ^d   Byun, Ki Yong ^e   Lee, Dong Chul ^f   Song, Eun Kyoo ^g   Son, Jung Hwan ^h  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

^c Seoul National University   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Chungnam National University   (South Korea)

^f Yeungnam University   (South Korea)

^g Chonnam National University   (South Korea)

^h Kosin University   (South Korea)

Author keywords

5 LOX; Anti inflammatory; Clinical study; Lequesne functional index; Lyprinol

Indexed keywords

ANTIINFLAMMATORY AGENT; LYPRINOL;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; JOINT FUNCTION; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSSEL; SIDE EFFECT; VISUAL ANALOG SCALE;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; BIVALVIA; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LIPIDS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; SAFETY; TISSUE EXTRACTS; TREATMENT OUTCOME;

EID: 0038801294     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Halpern G.-M. - Lyprinol. A natural solution for arthritis and other inflammatory disorders. Avery; New York. 2001;1 vol, 149 p.
2. Sinclair A.-J., Murphy K.-J., Li D. - New insights and lipid composition of Lyprinol. Allergie Immunol 2000;32:261-71.
3. Whitehouse M.-W., Macrides T.-A., Kalafatis N., Betts W.-H., Haynes D.-R., Broadbent J.- Anti-inflammatory activity of a lipid fraction (Lyprinal) from the NZ green-lipped mussel. Inflammopharmacol 1997;5:237-246.
4. th American Oil Chemists Society Annual Meeting, Seattle, May, 1997.
5. Miller T.-E., Dadd J., Ormrad D.-J., Geddes R.- Anti-inflammatory activity in glycogen extracted from Perna canaliculus. Agents Actions 1993;38:C139-42.
6. Kasuge T., Tsugi, K., Ishida H., Yamaguchi T. - Isolation of an antihistaminic substance from Perno canaliculus. Chem Pharm Bull 1986;34:4825-8.
7. Halpern G.-M. - Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allergie Immunol 2000;32:272-8.
8. Calder P.-C. - Immunamodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc Nutr Soc 1996;55:737-74.
9. Hightan T.-C., McArther A.-W. - Pilot study on the effect of New Zealand green mussel an rheumatoid arthritis. NZ Med J 1975;80:261-3.
10. Gibson R.-G., Gibson SLM. - Green-lipped mussel extract in arthritis. Lancet 1981;1:149.
11. Gibsan S.-L., Gibsan R.-G. - The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Complement Ther Med 1998;6:122-126.
12. Coughey D.-E., Grigor R.-R., Coughey E.-B., Young P., Gaw P.J., Stewart A.-W. Perna canaliculus in the treatment rheumatoid arthritis. Eur J Rheumatol Inflamm 1983;6:197-200.
13. Larkin J.-G., Capell H.-A., Sturrock R.-D. - Seatane in rheumatoid arthritis: a six-month placebo-controlled study. Ann Rheum Dis 1985;44:199-201.
14. Emelyanav A., Fedaseev G., Krasnoschekova O., Abulimity A., Trendeleva T., Barnes P.- Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Resp J 2002;20:596-600.
15. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K et al.- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-514.
16. Altmon R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K et al. - Development of criteria for the classification and reporting of osteoorthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-1049.
17. Lequesne M.-G., Méry C., Samson M.- Indexes of severity for osteoarthritis of the hip and knee. Scond J Rheumatol Suppl 1987;65:85-9.
18. Dugas B. - Lyprinol inhibits IL-4 induced LTB4 production by human monocytes. Allergie Immunol 2000;32:284-90.